Search Results 201-210 of 16977 for Fibroma

  1. Neonatally-Derived Tissues for Biotherapeutic Manufacturing - Mayo Clinic

    About this study. The purpose of this study is to create a shared Mayo Clinic resource for biotherapies derived from various perinatal tissues (umbilical ...

  2. Neurofibromatosis type 1 - Doctors and departments - Mayo Clinic

    Mayo Clinic researchers study genetics, causes and new treatments for people with neurofibromatosis type 1. Research is conducted by Mayo Clinic researchers in ...

  3. Oncology (Medical) - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  4. Oncology (Medical) - Clinical trials

    [MUSIC PLAYING]. Joseph Sirven, M.D., Professor of Neurology, Mayo Clinic: Mayo's mission is about the patient. The patient comes first.

  5. Mayo Clinic Radio: Treatment options for uterine fibroids

    Other uterine fibroids become large and can cause severe abdominal pain and heavy menstruation. The NIH reports that more than 200,000 hysterectomies are ...

  6. Uterine fibroids - Doctors and departments - Mayo Clinic

    Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.

  7. Fibromyalgia - Doctors and departments - Mayo Clinic

    This complicated disorder amplifies painful sensations by affecting the way your brain processes pain signals. Medications, therapy and exercise can help.

  8. A Study to Evaluate Gemcitabine and MK-3475 (Pembrolizumab) to Treat Patients with BCG-Unresponsive Non-Muscle Invasive Bladder Cancer - Mayo Clinic

    The purpose of this study is to assess the effect of adding pembrolizumab to gemcitabine in treating patients with non-muscle invasive bladder cancer whose ...

  9. Uterine fibroids - Doctors and departments - Mayo Clinic

    Learn about these common noncancerous growths and what to do if you have symptoms such as heavy menstrual bleeding.

  10. A Phase II Study Evaluating the Safety and Efficacy of Subcutaneous Plerixafor - Mayo Clinic

    This is a Phase II, open-label, two strata, multicenter, prospective study of plerixafor-mobilized HLA-identical sibling allografts in recipients with ...